1. Simonson M, Li Y, Zhu B, McAnany JJ, Chirakalwasan N, Sutabutr Vajaranant T, Hanlon EC, Pannain S, Anothaisintawee T, Reutrakul S. Multidimensional sleep health and diabetic retinopathy: Systematic review and meta-analysis. Sleep Med Rev. 2024;74:101891.
2. Changsiripun C, Chirakalwasan N, Dias S, McDaid C. Management of primary snoring in adults: A scoping review examining interventions, outcomes and instruments used to assess clinical effects. Sleep Med Rev. 2024;77:101963.
3. Changsiripun C, Chirakalwasan N, Dias S, McDaid C. Management of primary snoring in adults: A scoping review examining interventions, outcomes and instruments used to assess clinical effects. Sleep Med Rev. 2024;77:101963.
4. BaHammam AS, Al-Abri MA, Rashid RA, Amra B, Al Oweidat K, Chan JWY, Chen NH, Chirakalwasan N, Dizon RV Jr, Gupta R, Duong-Quy S, Han F, Hong SB, Jihui Z, Jahrami H, Jamil MG, Jung KY, Kadotani H, Leow LC, Lee PL, Shin W, Xu L, Wing YK, Inoue Y; Asian Society of Sleep Medicine Research Group. Mapping the landscape of sleep medicine training across Asia. J Clin Sleep Med. 2024 Jun 19. doi: 10.5664/jcsm.11240
5. Sriprasart T, Saiphoklang N, Kawamatawong T, Boonsawat W, Mitthamsiri W, Chirakalwasan N, Chiewchalermsri C, Athipongarporn A, Kamalaporn H, Kornthatchapong K, Kulpraneet M, Sompornrattanaphan M, Oer-Areemitr N, Rerkpattanapipat T, Silairatana S, Thawanaphong S, Gaensan T, Jirakran K, Poachanukoon O. Allergic rhinitis and other comorbidities associated with asthma control in Thailand. Front Med (Lausanne). 2024 Jan 11;10:1308390
6. Dadphan N, Chalidapongse P, Muntham D, Chirakalwasan N. Prevalence and predictors of sleep bruxism in patients with obstructive sleep apnea and the effect of positive airway pressure treatment. Sleep Breath. 2024;28(3):1119-25.
7. Promsod O, Kositanurit W, Tabtieang T, Kulaputana O, Chirakalwasan N, Reutrakul S, Sahakitrungruang T. Impact of irregular sleep pattern, and sleep quality on glycaemic parameters and endothelial function in adolescents and young adults with type 1 diabetes. J Sleep Res. 2024;33(4):e14110.
|
Insomnia and obstructive sleep apnea (OSA) commonly co-occur and this entity was defined as Co-Morbid Insomnia and Sleep Apnea (COMISA).
Approximately 30-50% of patients with OSA report clinically significant insomnia symptoms, and 30-40% of patients with chronic insomnia met diagnostic criteria for OSA.1 The importance of these two conditions together will cause patients to have worse sleep, mental health, physical health, quality of life and longevity compared to people with neither condition and to those with each condition alone.2 Underlying low respiratory arousal threshold as one of the endotypes of OSA has been identified as one of possible underlying causes of COMISA. Treatment with Cognitive Behavioral Therapy for Insomnia (CBT-i) before or concurrent with the treatment of OSA have been shown to improve CPAP usage.3 Due to limited availability of CBT-i, internet based CBT-i has been shown to be effective. 4 Emerging therapeutic alternatives for COMISA include non-CPAP alternative therapies and hypnotics targeting respiratory arousal threshold. 2
References:
1. Sweetman A, Lack L, McEvoy RD, et al. Bi-directional relationships between co-morbid insomnia and sleep apnea (COMISA). Sleep Med Rev. 2021;60:101519.
2. Sweetman A, Osman A, Lack L, et al. Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions. Curr Opin Pulm Med. 2023;29(6):567-73.
3. Sweetman A, Lack L, Bastien C. Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials. Brain Sci. 2019;9(12):371.
4. Theppornpitak W, Hemrungrojn S, Thienwiwatnukul K, Muntham D, Chirakalwasan N, Srisawart P. Effectiveness of internet-based CBT-I for the treatment of chronic subthreshold to moderate insomnia. Front Neurol. 2023 Jun 2;14:1180339.
|